VersaPeutics is a privately held specialty pharmaceutical company focusing on discovering and advancing novel therapeutic approaches for Alzheimer’s disease. As the proprietary scientific platform of VersaPeutics is built upon novel approaches to regulate the Wnt/planar cell polarity (PCP) signaling pathway, additional therapeutic areas within our focus include spinal cord injury, neuropathic pain, and oncology.

‍